Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.gianpathlabs.com | |
Market Cap | 20.17 Cr. | |
Enterprise Value(EV) | 21.44 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.34 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 14.60 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 60.78 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 15.07 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.29 | Calculated using Price: 19.50 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.03 Cr. | 10,341,527 Shares |
FaceValue | 10 | |
About Gian Life Care Ltd. | ||
The company is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers. The company offers various tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services. |
1 Day |
|
-1.34% |
1 Week |
|
-4.30% |
1 Month |
|
-6.55% |
3 Month |
|
-9.21% |
6 Month |
|
-13.44% |
1 Year |
|
-4.35% |
2 Year |
|
-59.53% |
5 Year |
|
|
10 Year |
|
1 years | 2022-03 | |
Return on Equity (%) | 31.16 | |
Return on Capital Employed (%) | 44.24 | |
Return on Assets (%) | 18.95 |
Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 14 | 15 | 16 | |
Non Curr. Liab. | 2 | 2 | 2 | |
Curr. Liab. | 7 | 11 | 13 | |
Minority Int. | ||||
Equity & Liab. | 23 | 28 | 30 | |
Non Curr. Assets | 13 | 17 | 18 | |
Curr. Assets | 10 | 11 | 12 | |
Misc. Exp. not W/O | ||||
Total Assets | 23 | 28 | 30 |
Particulars | 2 years | 2022-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 16 | 11 | |
Other Income | 1 | 1 | |
Total Income | 16 | 12 | |
Total Expenditure | -9 | -9 | |
PBIDT | 7 | 3 | |
Interest | -1 | 0 | |
Depreciation | 0 | -1 | |
Taxation | -1 | -1 | |
Exceptional Items | |||
PAT | 4 | 1 | |
Minority Interest | |||
Share Associate | |||
Other Related Items | |||
Consolidated Net Profit | 4 | 1 | |
Adjusted EPS | 4 | 1 |
Particulars | 1 years | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 6 | |
Cash Fr. Inv. | -4 | |
Cash Fr. Finan. | 1 | |
Net Change | 2 | |
Cash & Cash Eqvt | 5 |
Tue, 14 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Submission of Newspaper Publications |
Sat, 11 Nov 2023
Results For The Period Ended September 30 2023 Dear Sir/ Maam Please find attached herewith Unaudited Standalone and Consolidated Financial Results for the quarter/ half year ended September 30 2023. For Gian Life Care Limited |
Sat, 11 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday November 11 2023 Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today i.e. November 11 2023 has inter-alia considered and approved the following:-1. Unaudited Standalone and Consolidated Financial results of the Company for the quarter/ half year ended 30th September 2023. (Copy enclosed along with Limited Review Report). The Board Meeting commenced at 02:30 P.M and concluded at 03.30 P.M.You are requested to kindly take the above information in your records.Thanking You Yours faithfully For GIAN LIFE CARE LIMITED |
Tue, 28 Nov 2023 |
|
|
|
|
|